Amreen Husain

Dr. Amreen Husain serves as the Chief Medical Officer at RayzeBio, a biotechnology company specializing in targeted radiopharmaceuticals for cancer treatment. In her role, she oversees clinical development strategies to advance innovative oncology therapies. With extensive experience in clinical research and drug development, Dr. Husain brings valuable insights into optimizing clinical trial processes. She will be contributing to the “Panel Discussion: Identifying Delays in Clinical Research to Streamline Development,” where her expertise will shed light on accelerating therapeutic advancements.